Aptamer-mediated hollow MnO2 for targeting the delivery of sorafenib
Sign Up to like & getrecommendations! Published in 2022 at "Drug Delivery"
DOI: 10.1080/10717544.2022.2149897
Abstract: Abstract Sorafenib (SRF) presents undesirable effects in clinical treatment, due to the lack of targeting, poor water solubility, and obvious side effects. In this study, we constructed a novel nanodrug carrier system for accurate and… read more here.
Keywords: mno2; srf; mno2 srf; sorafenib ... See more keywords